Gene · 3594
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineering cytokines for cancer immunotherapy: a systematic review. | Front Immunol | 2023 | 37483629 | PubTator, text mining | PubMed |
| Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients. | Front Immunol | 2023 | 37483622 | PubTator, text mining | PubMed |
| Uncovering accurate prognostic markers for high-risk uveal melanoma through DNA methylation profiling. | Clin Transl Med | 2023 | 37478301 | PubTator, text mining | PubMed |
| A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma. | Cell Rep Med | 2023 | 37467717 | PubTator, text mining | PubMed |
| Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products. | Front Immunol | 2023 | 37457696 | PubTator, text mining | PubMed |
Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary-progressive and relapsing-remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases. | Health Sci Rep | 2023 | 37448727 | PubTator, text mining | PubMed |
| Chemokine Heteromers and Their Impact on Cellular Function-A Conceptual Framework. | Int J Mol Sci | 2023 | 37446102 | PubTator, text mining | PubMed |
| Interleukin 12 in the Acute Phase of the Immune Response after Excimer Laser Treatment. | J Clin Med | 2023 | 37445506 | PubTator, text mining | PubMed |
| The Evolutionary Scenario of Pediatric Unclassified Primary Antibody Deficiency to Adulthood. | J Clin Med | 2023 | 37445241 | PubTator, text mining | PubMed |
| Effects of radiation therapy on tumor microenvironment: an updated review. | Chin Med J (Engl) | 2023 | 37442768 | PubTator, text mining | PubMed |
| Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis. | Clin Transl Gastroenterol | 2023 | 37440754 | PubTator, text mining | PubMed |
| Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease. | PLoS Negl Trop Dis | 2023 | 37440604 | PubTator, text mining | PubMed |
| Novel mutations in genes of the IL-12/IFN-γ axis cause susceptibility to tuberculosis. | J Infect Public Health | 2023 | 37437430 | PubTator, text mining | PubMed |
| Innate immune responses in Behçet disease and relapsing polychondritis. | Front Med (Lausanne) | 2023 | 37435539 | PubTator, text mining | PubMed |
| Identification and validation of m6A-GPI signatures as a novel prognostic model for colorectal cancer. | Front Oncol | 2023 | 37427112 | PubTator, text mining | PubMed |
| Diagnosis of post-neurosurgical bacterial meningitis in patients with aneurysmal subarachnoid hemorrhage based on the immunity-related proteomics signature of the cerebrospinal fluid. | Front Neurol | 2023 | 37409018 | PubTator, text mining | PubMed |
| The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease. | Int J Mol Sci | 2023 | 37373318 | PubTator, text mining | PubMed |
| Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer. | Ther Adv Urol | 2023 | 37359737 | PubTator, text mining | PubMed |
| 3D genome organization and epigenetic regulation in autoimmune diseases. | Front Immunol | 2023 | 37346038 | PubTator, text mining | PubMed |
| Characterization of HZ0412a, a novel potent humanized anti-IL-6 receptor antibody that blocks IL-6R binding to gp130. | Antib Ther | 2023 | 37324549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3594/papers?page=9